Results 41 to 50 of about 41,400 (225)

Ischemic Stroke Post-Transradial Chemoembolization

open access: yesThe Arab Journal of Interventional Radiology
Transarterial chemoembolization is one of the approved locoregional treatment options for hepatocellular carcinoma. The procedure is safe; however, stroke may happen as one of the rarest complications.
Almamoon I. Justaniah   +2 more
doaj   +1 more source

INTERVENTIONAL SURGERY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER

open access: yesВестник урологии, 2015
During the period from 2004 to 2014, prostatic artery embolization was performed in 59 patients with benign prostatic hyperplasia (BPH) and superselective chemoembolization in 36 patients with prostate cancer.
A. I. Neymark   +4 more
doaj   +1 more source

Chemoembolization with cisplatin-microcapsule.

open access: yesNippon Jibiinkoka Gakkai Kaiho, 1985
Cisplatin (CDDP) was microcapsulated with ethylcellulose. These CDDP-microcapsules (CDDP-m. c.) were prepared based on the principles of coacervation, with modification. Sustained release of CDDP from the microcapsule, especially non-protein-bound CDDP which has antitumor activity, was clearly demonstrated by an invitro test.
Y, Okamoto   +6 more
openaire   +3 more sources

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies [PDF]

open access: yes, 2019
Background and Aims: While transarterial chemoembolization (TACE) represents a standard of therapy for intermediate-stage hepatocellular carcinoma (HCC) and is also routinely performed in patients with liver metastases, it is still debated which ...
Bruners, Philipp   +7 more
core   +1 more source

Transcatheter arterial chemoembolization for lung malignant tumors

open access: yesFrontiers in Oncology
Transcatheter arterial chemoembolization may enhance the local concentration and cytotoxicity of chemotherapeutic drugs and block the blood supply to the tumor, with an expectation to control the tumor, relieve hemoptysis, and prolong survival.
Fenxiang Zhang, Yujin Liu
doaj   +1 more source

Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads

open access: yesJournal of Hepatocellular Carcinoma, 2021
Wei-Chou Chang,1 Hsian-He Hsu,1 Sung-Hua Chiu,1 Wen-Yen Huang,2 Cheng-Hsiang Lo,2 Hsuan-Hwai Lin,3 Pei-Ching Huang,4 Yu-Lueng Shih,3 Yung-Liang Wan4 1Department of Radiology, Tri-Service General Hospital and National Defense Medical Center, Taipei ...
Chang WC   +8 more
doaj  

Inflammatory markers as prognostic factors of survival in patients affected by hepatocellular carcinoma undergoing transarterial chemoembolization [PDF]

open access: yes, 2017
Transarterial chemoembolization (TACE) is a good choice for hepatocellular carcinoma (HCC) treatment when surgery and liver transplantation are not feasible.
Brunese, L.   +11 more
core   +3 more sources

Engineering a Sonotherapeutic RBC Membrane‐Derived Nanoparticle Platform for the Treatment of Liver Cancer

open access: yesAdvanced Functional Materials, EarlyView.
Herein, an RBC membrane‐derived nanoparticle (CMN‐ICG) is engineered to efficiently deliver a sonosensitizing agent, indocyanine green (ICG), for sonotherapy of hepatocellular carcinoma (HCC). CMN‐ICG exhibits excellent cytocompatibility, significantly enhances hepatocyte uptake, and produces excessive reactive oxygen species (ROS) upon ultrasound ...
Alap Ali Zahid   +6 more
wiley   +1 more source

Arterial chemoembolization with cisplatin microcapsules [PDF]

open access: yesBritish Journal of Cancer, 1986
Cisplatin (CDDP) was microcapsulated with ethylcellulose. Sustained release of CDDP from the microcapsule, particularly non-protein-bound CDDP, which should have antitumour activity, was demonstrated by an in vitro test. Using a bioassay, it was proven that the biological activity of CDDP was not affected by the microencapsulation process. When CDDP-mc
Y, Okamoto   +5 more
openaire   +2 more sources

Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma [PDF]

open access: yes, 2008
Background: Hepatocellular carcinoma (HCC) is the third most common cause of cancer deaths. Difficulties to diagnose HCC at early stages remain the major obstacle to curative (surgical) therapy. Therapy in advanced stages has to be considered palliative.
Bartelheim, Kerstin   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy